Researchers evaluated the association between the use of various hormonal contraceptives and the risk for surgically treated intracranial meningioma.

Studies show Depo-Provera users have much higher relative risk of developing meningiomas, although overall risk remains low ...

Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain tumours by as much as 500 per cent.

Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain ...

Approximately 19 million U.S. women of childbearing age reside in what are known as “contraceptive deserts” due to geographic, political, economic and social barriers to birth control. Women living in ...

Researchers at Boston-based Mass General Brigham and MIT have developed a long-acting contraceptive injection designed to be delivered through tiny needles, reducing discomfort and increasing ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Sadie Rose, Vogelzang Law’s bankruptcy ...

Guests and partners in the launch of private sector Depo Medroxy Progesterone Subcutaneous( DMPA- SC) contraceptive which is self-injected. [ Jenipher Wachie, Standard] Pharmacies will now serve as ...

NEW YORK (Reuters Health) - A study shows that women who use the injectable contraceptive DMPA (depot medroxyprogesterone acetate) are apt to experience a significant increase in body weight and fat.